Company announcement no. 37-2023
The board of directors of Audientes A/S, CVR. No. 36 04 76 31 (the "Company"), hereby convenes an extraordinary general meeting in the Company to be held
Agenda
The extraordinary general meeting has been called for transaction of the following agenda:
- Appointment to the board of directors
-
Authorization to inform the
Danish Business Authority of decisions taken at the extraordinary general meeting - Any other business
Agenda with complete proposed resolutions
Re item 1: Appointment to the board of directors
Re item 1: Appointment to the board of directors
Mr.
Before the election to the board of directors, information was submitted on his managerial offices in other commercial enterprises except from 100 pct. owned subsidiaries, cf. the companies act section 120(3), as detailed in Appendix 1 of the attached Notice of Extraordinary General Meeting.
Re item 2: Authorisation for registering of the resolutions made at the extraordinary general meeting with the Danish Business Authority
The Board of directors proposes that
Requirements for resolutions
The proposal under items 1 and 2 may be adopted by a simple majority of votes.
Share capital and voting rights
Share capital and voting rights
The share capital of the Company is
Registration date of shares held by the shareholder
The registration date of shares held by the shareholder is
A shareholder's right to participate in the extraordinary general meeting and to cast vote is determined on basis of the shares held by the shareholder on the registration date. In addition, participation in the extraordinary general meeting is conditional upon the shareholder having registered in due time as described below.
Registration for the extraordinary general meeting
Access to the extraordinary general meeting is conditional on the shareholder registering for the extraordinary general meeting no later than
The registration shall be made via the Investor Portal at:
· The Company's website: www.audientes.com/investor-relations
· At the website of
· By sending an e-mail to: CPH-investor@euronext.com
After registration, the shareholder will receive an e-mail (at the e-mail address the shareholder has provided as part of registration) confirming the registration and information on the procedure relating to participation. The information on participation may also be accessed through www.audientes.com/investor-relations.
A shareholder or a holder of a proxy can participate in the extraordinary general meeting together with an adviser, provided that notification of the adviser's participation has been provided.
Questions concerning registration for the extraordinary general meeting or the use of the investor portal, may be answered by Audientes A/S, Investor Relations, by calling the Company on + 45 77 34 16 80 (weekdays
Proxy or Postal vote
If the shareholder is unable to attend the extraordinary general meeting, the shareholder can:
· issue a proxy to a named third party who will then receive from
· issue a proxy to the Board of directors for voting in accordance with the recommendations of the Board of directors; or
· issue a proxy to the Board of directors for voting in accordance with the shareholders instructions; or
· vote by postal vote.
The shareholder can submit the vote or issue a proxy electronically via the Company's InvestorPortal available from its website www.audientes.com/investor-relations or at www.euronext.com/cph-agm.
Alternatively, the proxy form or the postal vote form may be downloaded from www.audientes.com/investor-relations, printed and sent by email to CPH-investor@euronext.com or by ordinary mail to
The proxy must be received by
Postal votes cannot be revoked.
Additional information
For a period of at least two weeks prior to the extraordinary general meeting, including the day of the extraordinary general meeting, the following information will be available on the Company's website www.audientes.com/investor-relations:
· Notice convening the extraordinary general meeting including agenda and complete proposals.
· Information on the aggregate number of shares and voting rights as of the date of the notice convening the extraordinary general meeting.
· Documents that will be submitted at the extraordinary general meeting, including Bio of the candidate(s) for the board of directors.
· Registration form.
· Proxy and postal vote form.
Prior to the extraordinary general meeting, the shareholders can in writing ask questions to the Company regarding the agenda and/or the documents prepared for the extraordinary general meeting.
In the interest of proceedings and to the extent possible, the board of directors encourages shareholders to submit questions in writing ahead of the extraordinary general meeting.
Written enquiries can be sent to Audientes A/S via email to st@audientes.com or via post to Audientes A/S, Teknikerbyen 5, 2., Søllerød, 2830 Virum, att. CEO
Processing of personal data
With reference to the Danish Companies Act requirements, the Company processes personal information about its shareholders as part of the administration of the company's register of shareholders and other communication hereunder also related to the extraordinary general meeting. The following information is processed:
For further information about Audientes A/S, please contact:
Phone: +45 77 34 16 80
Email: st@audientes.com
About Audientes A/S
Audientes A/S is a Danish hearing health company specializing in smart, self-fitting and affordable hearing aids and advanced hearables. Audientes' unique self-fitting hearing aid solution, Ven™ by Audientes, is available for purchase in
Audientes' mission is to make high-quality hearing aids and hearables for hearing improvement or hearing enhancement accessible to everyone who needs them globally. Audientes is listed on Spotlight Stock Market Denmark (AUDNTS) and headquartered in
For additional information please refer to the company's websites, www.audientes.com, www.audientes.eu or www.audientes.in.
https://news.cision.com/audientes/r/notice-of-extraordinary-general-meeting-at-audientes-a-s,c3893708
https://mb.cision.com/Main/21235/3893708/2494491.pdf
(c) 2023 Cision. All rights reserved., source